Though the former president has repeatedly hyped the impact of his experimental drug program, there’s no basis for his claims in government data, and medical experts say he’s exaggerating.
In this Month in Review summary, some of the most notable advancements and developments in the field of dermatology were highlighted.
Donald Trump’s pledge to let Robert F. Kennedy Jr. “go wild on health” has put three issues on the agenda in the final days of…
Scientists in Japan have created hybrid plant-animal cells, essentially making animal cells that can gain energy from sunlight like plants. The breakthrough could have major…
Vertex Pharmaceuticals raised its annual revenue forecast on Monday after it beat third-quarter estimates on demand for its cystic fibrosis (CF) treatments.
Tactile controls are making a comeback! Many companies are adding physical buttons and knobs back to their devices, moving away from touchscreens that have been…
With Ambry Genetics in tow, Eric Lefkofsky’s biotech startup hopes to accelerate its drive toward turning a profit.
Opinion: A new study finds that doctors really do judge patients negatively when they share false beliefs.
After the FDA delayed the approval of MDMA-assisted therapy for PTSD, there’s still a way forward for psychedelic medicines, experts said at HLTH.
Energy planners say Labour’s 2030 electricity net zero target is “achievable” but a “huge challenge”.
While VBC opens the door to new care models, they alone cannot solve another key driver of healthcare costs: many people are diagnosed late in…
